// startup autopsy
Repromedix
Diagnosing male infertility in a market that wasn't ready
marketfitSilent Shutdown
Quiet closure with no public announcement · Fatal mistake: Underestimated the complexity of insurance reimbursement and clinical workflow integration required to achieve sustainable commercial adoption.
| Founded | 2010 |
|---|---|
| Closed | 2016 |
| Country | USA |
| Sector | Healthtech |
50%
50%
Key Events Timeline
FOUNDING
Repromedix founded to commercialize advanced male reproductive health diagnostics for fertility clinics.
PRODUCT LAUNCH
Launched proprietary diagnostic testing panels targeting fertility specialists, receiving limited but enthusiastic early clinical uptake.
FUNDING
Secured funding to expand commercial operations and pursue insurance reimbursement approvals for its diagnostic tests.
SHUTDOWN
Repromedix ceased operations after failing to achieve sufficient clinical adoption and reimbursement coverage to sustain the business.